Abou-Khalil, B (2008). Levetiracetam in the treatment of epilepsy. Neuropsychiatric Disease and Treatment 4, 507–523.
Blickwedel, J, Ali, A, Hassiotis, A (2017). Epilepsy and challenging behaviour in adults with intellectual disability: a systematic review. Journal of Intellectual & Developmental Disability. https://doi.org/10.3109/13668250.2017.1327039.
Braakman, HM, Vaessen, MJ, Hofman, PA, Debeij-van Hall, MH, Backes, WH, Vles, JS, Aldenkamp, AP (2011). Cognitive and behavioral complications of frontal lobe epilepsy in children: a review of the literature. Epilepsia 52, 849–856.
Clarke, MC, Tanskanen, A, Huttunen, MO, Clancy, M, Cotter, DR, Cannon, M (2012). Evidence for shared susceptibility to epilepsy and psychosis: a population-based family study. Biological Psychiatry 71, 836–839.
Espie, CA, Watkins, J, Duncan, R, Sterrick, M, McDonach, E, Espie, E, McGarvey, C (2003). Perspectives on epilepsy in people with intellectual disabilities: comparison of family carer, staff carer and clinician score profiles on the Glasgow Epilepsy Outcome Scale (GEOS). Seizure 12, 195–202.
Fisher, RS, Acevedo, C, Arzimanoglou, A, Bogacz, A, Cross, JH, Elger, CE, Engel, J, Forsgren, L, French, JA, Glynn, M, Hesdorffer, DC, Lee, BI, Mathern, GW, Moshé, SL, Perucca, E, Scheffer, IE, Tomson, T, Watanabe, M, Wiebe, S (2014). ILAE official report: a practical clinical definition of epilepsy. Epilepsia 55, 475–482.
Fisher, RS, Vickrey, BG, Gibson, P, Hermann, B, Penovich, P, Scherer, A, Walker, S (2000). The impact of epilepsy from the patient’s perspective I. Descriptions and subjective perceptions. Epilepsy Research 41, 39–51.
Flor-Henry, P (1969). Psychosis and temporal lobe epilepsy: a controlled investigation. Epilepsia 10, 363–395.
Getnet, A, Woldeyohannes, SM, Bekana, L, Mekonen, T, Fekadu, W, Menberu, M, Yimer, S, Assaye, A, Belete, A, Belete, H (2016). Antiepileptic drug nonadherence and its predictors among people with epilepsy. Behavioural Neurology 2016, 1–6.
Gold, JA, Sher, Y, Maldonado, JR (2016). Frontal lobe epilepsy: a primer for psychiatrists and a systematic review of psychiatric manifestations. Psychosomatics 57, 445–464.
Gutierrez-Angel, AM, Martinez-Juarez, IE, Hernandez-Vanegas, LE, Crail-Melendez, D (2018). Quality of life and level of burden in primary caregivers of patients with epilepsy: Effect of neuropsychiatric comorbidity. Epilepsy & Behavior 81, 12–17.
Harpin, VA (2008). Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006. Archives of Disease in Childhood – Education and Practice 93, 58–65.
Hillbom, M, Pieninkeroinen, I, Leone, M (2003). Seizures in alcohol-dependent patients: epidemiology, pathophysiology and management. CNS Drugs 17, 1013–1030.
Jones, R, Rickards, H, Cavanna, AE (2010). The prevalence of psychiatric disorders in epilepsy: a critical review of the evidence. Functional Neurology 25, 191–194.
Kanner, AM, Rivas-Grajales, AM (2016). Psychosis of epilepsy: a multifaceted neuropsychiatric disorder. CNS Spectrums 21, 247–257.
Kerr, M, Linehan, C, Brandt, C, Kanemoto, K, Kawasaki, J, Sugai, K, Tadokoro, Y, Villanueva, V, Wilmshurst, J, Wilson, S (2016). Behavioral disorder in people with an intellectual disability and epilepsy: a report of the Intellectual Disability Task Force of the Neuropsychiatric Commission of ILAE. Epilepsia Open 1, 102–111.
Linehan, C, Walsh, P, Kerr, M, Brady, G, Kelleher, C (2009). The prevalence of epilepsy in Ireland: a summary report. Brainwave, the Irish Epilepsy Association, Dublin. (http://www.epilepsy.ie/assets/16/BB1D6D7E-D941-18FF-F8010F269F3E5E29_document/Prevalence_Summary.pdf). .
Loganathan, MA, Enja, M, Lippmann, S (2015). Forced normalisation: epilepsy and psychosis interaction. Innovations in Clinical Neuroscience 12, 38–41.
McEwan, L, Taylor, J, Caswell, M, Entwistle, R, Jacoby, K, Gorry, J, Jacoby, A, Baker, GA (2007). Knowledge of and attitudes expressed toward epilepsy by carers of people with epilepsy: a UK perspective. Epilepsy & Behavior 11, 13–19.
Moloney, N, Smithwick, D, Mullane, N, O’Sullivan, D, Gulati, G (2017). Epilepsy in psychiatric inpatient settings: the “Yellow Card” initiative – a completed audit cycle from the Mid-West. Poster Presented at the Annual Psychiatry Study Day at the University of Limerick, .
Murray, RM, Lewis, SW (1987). Is schizophrenia a neurodevelopmental disorder? British Medical Journal 295, 681–682.
Murphy, V, Gulati, G, Luppe, S, Chaila, E (2017). Epilepsy care planning in psychiatric inpatient settings – the ‘Yellow Card’. International Journal of Integrated Care 17, A553.
Murphy, V, Hallahan, B, Moloney, M, Smthwick, D, Costello, S, Gulati, G (2018). Epilepsy in Irish psychiatric inpatients settings. Irish Medical Journal 111, 809.
Nadkarni, S, Devinsky, O (2005). Psychotropic effects of antiepileptic drugs. Epilepsy Currents 5, 176–181.
Oliveira, SN, Rosado, P (2004). EEG interictal – sensitivity and specificity of the diagnosis of epilepsy. Acta Médica Portuguesa 17, 465–470.
Ornoy, A (2009). Valproic acid in pregnancy: how much are we endangering the embryo and fetus? Reproductive Toxicology 28, 1–10.
Regier, DA, Farmer, ME, Rae, DS, Locke, BZ, Keith, SJ, Judd, LL, Goodwin, FK (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264, 2511–2518.
Robertson, J, Hatton, C, Emerson, E, Baines, S (2015). Mortality in people with intellectual disabilities and epilepsy: a systematic review. Seizure 29, 123–133.
Roy, T, Pandit, A (2011). Neuroimaging in epilepsy. Annals of Indian Academy of Neurology 14, 78–80.
Scott, RC, Besag, FM, Neville, BG (1999). Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial. Lancet 353, 623–626.
Shankar, R, Walker, M, McLean, B, Laugharne, R, Ferrand, F, Hanna, J, Newman, C (2016). Steps to prevent SUDEP: the validity of risk factors in the SUDEP and seizure safety checklist: a case control study. Journal of Neurology 263, 1840–1846.
Shankar, R, Elizabeth, JD, McLean, B, Nashef, L, Tomson, T (2017). Sudden unexpected death in epilepsy (SUDEP): what every neurologist should know. Epileptic Disorders 19, 1–9. https://doi.org/10.1684/epd.2017.0891.
Sisodiya, SM (2018). Valproate and childbearing potential: new regulations. Practical Neurology. . doi:10.1136/practneurol-2018-001955.
Stephen, LJ, Wishart, A, Brodie, MJ (2017). Psychiatric side effects and antiepileptic drugs: observations from prospective audits. Epilepsy & Behavior 71, 73–78.
Stern, TA, Murray, GB (1984). Complex partial seizures presenting as a psychiatric illness. The Journal of Nervous and Mental Disease 172, 625–627.
Taylor, DM, Barnes, TRE, Young, AH (2018). The Maudsley Prescribing Guidelines in Psychiatry, 13th edn. Wiley-Blackwell: London. ISBN 978-1-119-44260-8.
Taylor, DM, Paton, C, Kapur, S (2015). The Maudsley Prescribing Guidelines in Psychiatry, 12th edn. Wiley-Blackwell: London: ISBN: 978-1-118-75460-3.
Valenstein, M, Ganoczy, D, McCarthy, JF, Myra Kim, H, Lee, TA, Blow, FC (2006). Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review. Journal of Clinical Psychiatry 67, 1542–1550.
Williams, AE, Giust, JM, Kronenberger, WG, Dunn, DW (2016). Epilepsy and attention-deficit hyperactivity disorder: links, risks, and challenges. Neuropsychiatric Disease and Treatment 12, 287–296.
Young, C, Shankar, S, Palmer, J, Craig, J, Hargreaves, C, McLean, B, Cox, D, Hillier, R (2015). Does intellectual disability increase sudden unexpected death in epilepsy (SUDEP) risk? Seizure 25, 112–116.